Incidence of antibiotic-resistant Streptococcus pneumoniae and beta- lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media

Pediatric Infectious Disease Journal

Volumn 15, Issue 9 SUPPL., 1996, Pages

  McLinn, Samuel ^a   Williams, Debra ^b  

^a Scottsdale Pediatric Center   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

amoxicillin clavulanate; Azithromycin; beta lactamase; cephalosporin; clarithromycin; Haemophilus influenzae; otitis media; penicillin; Streptococcus pneumoniae; trimeth oprim sulfamethoxazole

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFIXIME; CLARITHROMYCIN; COTRIMOXAZOLE; LORACARBEF;

ARTICLE; BACTERICIDAL ACTIVITY; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; MAJOR CLINICAL STUDY; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BETA-LACTAMASES; CHILD; CLARITHROMYCIN; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029792507     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199609000-00001     Document Type: Article

References (38)

1. Schappert SM. Office visits for otitis media: United States, 1975-90. Advance data from Vital and Health Statistics of the Centers for Disease Control/National Center for Health Statistics No. 214. Hyattsville, MD: Public Health Service, 1992 (DHHS Publication (PHS) 92-1250). 1992;214:1-20.
2. Teele DW, Klein JO, Rosner B, Greater Boston Otitis Media Study Group. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 1989;160:83-94.
3. Pichichero ME. Therapeutic considerations for management of otitis media, sinusitis, and tonsillopharyngitis. Pediatr Asthma Allergy Immunol 1992;6:167-74.
4. Bluestone CD. Current therapy for otitis media and criteria for evaluation of new antimicrobial agents. Clin Infect Dis 1992;14(Suppl 2):S197-203.
5. Hansman D, Bullen MM. A resistant pneumococcus. Lancet 1967;2:264-5.
6. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med 1995;333:474-80.
7. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med 1995;333:481-6.
8. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J 1995;14:751-9.
9. Mason EO, Kaplan SL, Lamberth LB, Tillman J. Increased rate of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother 1992;36:1703-7.
10. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Texas day care center. Am J Dis Child 1990;14:923-7.
11. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-53.
12. Centers for Disease Control. Drug resistant Streptococcus pneumoniae: Kentucky and Tennessee, 1993. MMWR 1994; 43:23-5, 31.
13. Boken DJ, Chartrand SA, Goering RV, Kruger R, Harrison CJ. Colonization with penicillin-resistant Streptococcus pneumoniae in a child-care center. Pediatr Infect Dis J 1995;14:879-84.
14. Barnes DM, Whittier S, Gilligan PH, Soares S, Tomasz A, Henderson FW. Transmission of multidrug-resistant serotype 23F Streptococcus pneumoniae in group day care: evidence suggesting capsular transformation of the resistant strain in vivo. J Infect Dis 1995;171:890-6.
15. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
16. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
17. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
18. Fass RJ. Erythromycin, clarithromycin, and azithromycin: use of frequency distribution curves, scattergrams, and regression analyses to compare in vitro activities and describe cross-resistance. Antimicrob Agents Chemother 1993;37: 2080-6.
19. Guenzi E, Gasc AM, Sicard MA, Hakenbeck R. A two-component signal-transducing system is involved in competence and penicillin susceptibility in laboratory mutants of Streptococcus pneumoniae. Mol Microbiol 1994;12:505-15.
20. Jacoby GA. Prevalence and resistance mechanisms of common bacterial respiratory pathogens. Clin Infect Dis 1994;18: 951-7.
21. Schito GC, Pesce A, Debbia EA. Stability in the presence of widespread beta-lactamases: a prerequisite for the antibacterial activity of beta-lactam drugs. Drugs 1994;47(Suppl 3):1-9.
22. Bluestone CD, Stephenson JS, Martin LM. Ten-year review of otitis media pathogens. Pediatr Infect Dis J 1992;11:S7-11.
23. Lisby-Sutch SM, Nemec-Dwyer MA, Deeter RG, Gaur SM. Therapy of otitis media. Clin Pharm 1990;9:15-34.
24. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard M7-A3. Villanova, PA: National Committee for Clinical Laboratory Standards, 1994.
25. Munoz R, Musser JM, Crain M, et al. Geographic distribution of penicillin-resistant clones of Streptococcus pneumoniae: characterization by penicillin-binding protein profile, surface protein A typing, and multilocus enzyme analysis. Clin Infect Dis 1992;15:112-8.
26. Hardy DJ, Hensey DM, Beyer JM, Vojtko C, McDonald EJ, Fernandes PB. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988;32:1710-19.
27. Neu HC. Otitis media: antibiotic resistance of causative pathogens and treatment alternatives. Pediatr Infect Dis J 1995;14:S51-6.
28. Retsema J, Girard A, Schelkly W, et al. Spectrum and mode of action of azithromycin (CP-62 993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agents Chemother 1987;31:1939-47.
29. Hardy DJ. Extent and spectrum of the antimicrobial activity of clarithromycin. Pediatr Infect Dis J 1993;12:S99-105.
30. McCarty JM. Bacterial susceptibility and tympanocentesis in acute otitis media. Pediatr Infect Dis J 1995;14:S45-50.
31. Barry AL, Fuchs PC, Brown SD. Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics. J Antimicrob Chemother 1995;35:552-5.
32. Brown SD, Burton P, Rich T, Bouchillon SK, Yee YC. Susceptibility surveillance of U.S. respiratory pathogen isolates to newer macrolide and azalide antibiotics [Abstract A32]. In: Program and abstracts of the 94th general meeting of the American Society for Microbiology. Washington, DC: Books International, 1994:7.
33. Retsema JA, Girard AE, Brennan LA, Cimochowski CR, Faiella JA. Lack of emergence of significant resistance in vitro and in vivo to the new azalide antibiotic azithromycin. Eur J Clin Microbiol Infect Dis 1991;10:843-6.
34. Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25(Suppl A):73-82.
35. Girard AE, Cimochowski CR, Faiella JA. The unique pharmacokinetics of azithromycin in the gerbil model of middle ear infection [Abstract A-64]. In: Program and abstracts of the 91st general meeting of The American Society for Microbiology. Washington, DC: Books International, 1991:11.
36. Gladue RP, Bright GM, Isaacson RE, Newborg MF. In vitro and in vivo uptake of azithromycin (CP-62 993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother 1989;33:277-82.
37. Pukander J. Penetration of azithromycin into middle ear effusion in acute and secretory otitis media in children. Presented at the Second International Conference on Macrolides and Streptogamins, Venice, Italy, January 17 to 22, 1994.
38. McCracken GH. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J 1995; 14:424-8.